185 related articles for article (PubMed ID: 24350726)
1. Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.
Kuczma M; Kurczewska A; Kraj P
J Immunotoxicol; 2014 Oct; 11(4):319-27. PubMed ID: 24350726
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-mediated enhancement of T
Browning LM; Pietrzak M; Kuczma M; Simms CP; Kurczewska A; Refugia JM; Lowery DJ; Rempala G; Gutkin D; Ignatowicz L; Muranski P; Kraj P
Sci Signal; 2018 Aug; 11(545):. PubMed ID: 30154100
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3
Browning LM; Miller C; Kuczma M; Pietrzak M; Jing Y; Rempala G; Muranski P; Ignatowicz L; Kraj P
Cell Rep; 2020 Oct; 33(1):108219. PubMed ID: 33027660
[TBL] [Abstract][Full Text] [Related]
4. Bone Morphogenetic Proteins Shape T
Kraj P
Front Immunol; 2022; 13():865546. PubMed ID: 35418975
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
7. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
[TBL] [Abstract][Full Text] [Related]
8. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
9. SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ.
Madireddi S; Schabowsky RH; Srivastava AK; Sharma RK; Yolcu ES; Shirwan H
PLoS One; 2012; 7(8):e42459. PubMed ID: 22870329
[TBL] [Abstract][Full Text] [Related]
10. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma.
Scirka B; Szurek E; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L; Miazek A
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):553-564. PubMed ID: 28638937
[TBL] [Abstract][Full Text] [Related]
11. Bone Morphogenetic Protein Signaling Regulates Development and Activation of CD4(+) T Cells.
Kuczma M; Kraj P
Vitam Horm; 2015; 99():171-93. PubMed ID: 26279376
[TBL] [Abstract][Full Text] [Related]
12. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
13. Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy.
Sato K; Sato N; Xu B; Nakamura Y; Nagaya T; Choyke PL; Hasegawa Y; Kobayashi H
Sci Transl Med; 2016 Aug; 8(352):352ra110. PubMed ID: 27535621
[TBL] [Abstract][Full Text] [Related]
14. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS
J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.
Seo N; Hayakawa S; Takigawa M; Tokura Y
Immunology; 2001 Aug; 103(4):449-57. PubMed ID: 11529935
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: in the absence of TGF-β signaling in T cells, fewer CD103+ regulatory T cells develop, but exuberant IFN-γ production renders mice more susceptible to helminth infection.
Reynolds LA; Maizels RM
J Immunol; 2012 Aug; 189(3):1113-7. PubMed ID: 22753928
[TBL] [Abstract][Full Text] [Related]
20. A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis.
Chawla AS; Khalsa JK; Dhar A; Gupta S; Umar D; Arimbasseri GA; Bal V; George A; Rath S
Immunology; 2020 Jul; 160(3):295-309. PubMed ID: 32187647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
